➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

NAGLAZYME Drug Profile

Email this page to a colleague

« Back to Dashboard

Summary for Tradename: NAGLAZYME
Suppliers: see list1
Recent Clinical Trials: See clinical trials for NAGLAZYME
Recent Clinical Trials for NAGLAZYME

Identify potential brand extensions & biosimilar entrants

BioMarin PharmaceuticalN/A
Masonic Cancer Center, University of MinnesotaN/A
BioMarin PharmaceuticalPhase 4

See all NAGLAZYME clinical trials

Pharmacology for NAGLAZYME

Patent Text Search: US Patents for NAGLAZYME

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.